Suzhou Industrial Park

Home page > category report > Industries & Enterprises


Innovent awarded "the most influential pharmaceutical innovation enterprise"


Date:   |   Source:       Font Size:    A   A   A

The award ceremony of the 2nd Chinese pharmaceutical innovation brands selection was held at People's Daily on March 12. Innovent Biologics, Inc. from SIP was cited as "the most influential pharmaceutical innovation enterprise", the single one from bio-pharmaceutical industry.

"Chinese pharmaceutical innovation brands", sponsored by Chinese Academy of Medical Sciences, China Academy of Chinese Medical Sciences, China Pharmaceutical Innovation and Research Development Association and www.people.com.cn, is the most prestigious prize in China's bio-med circle. The prize is given to the drug, enterprise and individual that have made outstanding contributions in China's independent pharmaceutical innovation and added brilliance to "Chinese brands" from 2006 to 2015.

Since its inception in 2011, Innovent has been working on producing highly complex biopharmaceutical products that will be affordable to people in China and around the world. Innovent has built up a portfolio of 12 molecules targeted towards indications in cancer, ophthalmology, autoimmune disorders and cardiovascular diseases. Two of Innovent's pipeline products have been granted "National Mega Innovative Program" status. Besides, Innovent has built a high-end pharmaceutical production base in compliance with the standards of China, the US and the EU.

March 13, 2017